RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s clinical programs at the following investor conferences:
• 11th Annual JMP Securities Research Conference in San Francisco on Tuesday, May 15, 2012 at 11:30 a.m. Pacific Time
